Human Antithrombin III Market, Global Outlook and Forecast 2022-2028

July 2022 | 71 pages | ID: HAD503F65248EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Human Antithrombin III in global, including the following market information:

Global Human Antithrombin III Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Human Antithrombin III Market Sales, 2017-2022, 2023-2028, (K Bottles)

Global top five Human Antithrombin III companies in 2021 (%)

The global Human Antithrombin III market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lyophilized Form Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Antithrombin III include Grifols, Lee BioSolutions, ATryn, LFB, Shire, CSL Limited, Kedrion and Octapharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Antithrombin III manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Antithrombin III Market, by Form, 2017-2022, 2023-2028 ($ Millions) & (K Bottles)

Global Human Antithrombin III Market Segment Percentages, by Form, 2021 (%)

• Lyophilized Form
• Liquid Form

Global Human Antithrombin III Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Bottles)

Global Human Antithrombin III Market Segment Percentages, by Application, 2021 (%)

• Hmophilia
• Aplastic Anemia
• Heart Valve Disease
• Other

Global Human Antithrombin III Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Bottles)

Global Human Antithrombin III Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Antithrombin III revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Human Antithrombin III revenues share in global market, 2021 (%)

Key companies Human Antithrombin III sales in global market, 2017-2022 (Estimated), (K Bottles)

Key companies Human Antithrombin III sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Grifols
• Lee BioSolutions
• ATryn
• LFB
• Shire
• CSL Limited
• Kedrion
• Octapharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Human Antithrombin III Market Definition
1.2 Market Segments
  1.2.1 Market by Form
  1.2.2 Market by Application
1.3 Global Human Antithrombin III Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HUMAN ANTITHROMBIN III OVERALL MARKET SIZE

2.1 Global Human Antithrombin III Market Size: 2021 VS 2028
2.2 Global Human Antithrombin III Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Antithrombin III Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Human Antithrombin III Players in Global Market
3.2 Top Global Human Antithrombin III Companies Ranked by Revenue
3.3 Global Human Antithrombin III Revenue by Companies
3.4 Global Human Antithrombin III Sales by Companies
3.5 Global Human Antithrombin III Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Antithrombin III Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Antithrombin III Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Antithrombin III Players in Global Market
  3.8.1 List of Global Tier 1 Human Antithrombin III Companies
  3.8.2 List of Global Tier 2 and Tier 3 Human Antithrombin III Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Form - Global Human Antithrombin III Market Size Markets, 2021 & 2028
  4.1.2 Lyophilized Form
  4.1.3 Liquid Form
4.2 By Form - Global Human Antithrombin III Revenue & Forecasts
  4.2.1 By Form - Global Human Antithrombin III Revenue, 2017-2022
  4.2.2 By Form - Global Human Antithrombin III Revenue, 2023-2028
  4.2.3 By Form - Global Human Antithrombin III Revenue Market Share, 2017-2028
4.3 By Form - Global Human Antithrombin III Sales & Forecasts
  4.3.1 By Form - Global Human Antithrombin III Sales, 2017-2022
  4.3.2 By Form - Global Human Antithrombin III Sales, 2023-2028
  4.3.3 By Form - Global Human Antithrombin III Sales Market Share, 2017-2028
4.4 By Form - Global Human Antithrombin III Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Human Antithrombin III Market Size, 2021 & 2028
  5.1.2 Hmophilia
  5.1.3 Aplastic Anemia
  5.1.4 Heart Valve Disease
  5.1.5 Other
5.2 By Application - Global Human Antithrombin III Revenue & Forecasts
  5.2.1 By Application - Global Human Antithrombin III Revenue, 2017-2022
  5.2.2 By Application - Global Human Antithrombin III Revenue, 2023-2028
  5.2.3 By Application - Global Human Antithrombin III Revenue Market Share, 2017-2028
5.3 By Application - Global Human Antithrombin III Sales & Forecasts
  5.3.1 By Application - Global Human Antithrombin III Sales, 2017-2022
  5.3.2 By Application - Global Human Antithrombin III Sales, 2023-2028
  5.3.3 By Application - Global Human Antithrombin III Sales Market Share, 2017-2028
5.4 By Application - Global Human Antithrombin III Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Human Antithrombin III Market Size, 2021 & 2028
6.2 By Region - Global Human Antithrombin III Revenue & Forecasts
  6.2.1 By Region - Global Human Antithrombin III Revenue, 2017-2022
  6.2.2 By Region - Global Human Antithrombin III Revenue, 2023-2028
  6.2.3 By Region - Global Human Antithrombin III Revenue Market Share, 2017-2028
6.3 By Region - Global Human Antithrombin III Sales & Forecasts
  6.3.1 By Region - Global Human Antithrombin III Sales, 2017-2022
  6.3.2 By Region - Global Human Antithrombin III Sales, 2023-2028
  6.3.3 By Region - Global Human Antithrombin III Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Human Antithrombin III Revenue, 2017-2028
  6.4.2 By Country - North America Human Antithrombin III Sales, 2017-2028
  6.4.3 US Human Antithrombin III Market Size, 2017-2028
  6.4.4 Canada Human Antithrombin III Market Size, 2017-2028
  6.4.5 Mexico Human Antithrombin III Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Human Antithrombin III Revenue, 2017-2028
  6.5.2 By Country - Europe Human Antithrombin III Sales, 2017-2028
  6.5.3 Germany Human Antithrombin III Market Size, 2017-2028
  6.5.4 France Human Antithrombin III Market Size, 2017-2028
  6.5.5 U.K. Human Antithrombin III Market Size, 2017-2028
  6.5.6 Italy Human Antithrombin III Market Size, 2017-2028
  6.5.7 Russia Human Antithrombin III Market Size, 2017-2028
  6.5.8 Nordic Countries Human Antithrombin III Market Size, 2017-2028
  6.5.9 Benelux Human Antithrombin III Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Human Antithrombin III Revenue, 2017-2028
  6.6.2 By Region - Asia Human Antithrombin III Sales, 2017-2028
  6.6.3 China Human Antithrombin III Market Size, 2017-2028
  6.6.4 Japan Human Antithrombin III Market Size, 2017-2028
  6.6.5 South Korea Human Antithrombin III Market Size, 2017-2028
  6.6.6 Southeast Asia Human Antithrombin III Market Size, 2017-2028
  6.6.7 India Human Antithrombin III Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Human Antithrombin III Revenue, 2017-2028
  6.7.2 By Country - South America Human Antithrombin III Sales, 2017-2028
  6.7.3 Brazil Human Antithrombin III Market Size, 2017-2028
  6.7.4 Argentina Human Antithrombin III Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Human Antithrombin III Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Human Antithrombin III Sales, 2017-2028
  6.8.3 Turkey Human Antithrombin III Market Size, 2017-2028
  6.8.4 Israel Human Antithrombin III Market Size, 2017-2028
  6.8.5 Saudi Arabia Human Antithrombin III Market Size, 2017-2028
  6.8.6 UAE Human Antithrombin III Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Grifols
  7.1.1 Grifols Corporate Summary
  7.1.2 Grifols Business Overview
  7.1.3 Grifols Human Antithrombin III Major Product Offerings
  7.1.4 Grifols Human Antithrombin III Sales and Revenue in Global (2017-2022)
  7.1.5 Grifols Key News
7.2 Lee BioSolutions
  7.2.1 Lee BioSolutions Corporate Summary
  7.2.2 Lee BioSolutions Business Overview
  7.2.3 Lee BioSolutions Human Antithrombin III Major Product Offerings
  7.2.4 Lee BioSolutions Human Antithrombin III Sales and Revenue in Global (2017-2022)
  7.2.5 Lee BioSolutions Key News
7.3 ATryn
  7.3.1 ATryn Corporate Summary
  7.3.2 ATryn Business Overview
  7.3.3 ATryn Human Antithrombin III Major Product Offerings
  7.3.4 ATryn Human Antithrombin III Sales and Revenue in Global (2017-2022)
  7.3.5 ATryn Key News
7.4 LFB
  7.4.1 LFB Corporate Summary
  7.4.2 LFB Business Overview
  7.4.3 LFB Human Antithrombin III Major Product Offerings
  7.4.4 LFB Human Antithrombin III Sales and Revenue in Global (2017-2022)
  7.4.5 LFB Key News
7.5 Shire
  7.5.1 Shire Corporate Summary
  7.5.2 Shire Business Overview
  7.5.3 Shire Human Antithrombin III Major Product Offerings
  7.5.4 Shire Human Antithrombin III Sales and Revenue in Global (2017-2022)
  7.5.5 Shire Key News
7.6 CSL Limited
  7.6.1 CSL Limited Corporate Summary
  7.6.2 CSL Limited Business Overview
  7.6.3 CSL Limited Human Antithrombin III Major Product Offerings
  7.6.4 CSL Limited Human Antithrombin III Sales and Revenue in Global (2017-2022)
  7.6.5 CSL Limited Key News
7.7 Kedrion
  7.7.1 Kedrion Corporate Summary
  7.7.2 Kedrion Business Overview
  7.7.3 Kedrion Human Antithrombin III Major Product Offerings
  7.7.4 Kedrion Human Antithrombin III Sales and Revenue in Global (2017-2022)
  7.7.5 Kedrion Key News
7.8 Octapharma
  7.8.1 Octapharma Corporate Summary
  7.8.2 Octapharma Business Overview
  7.8.3 Octapharma Human Antithrombin III Major Product Offerings
  7.8.4 Octapharma Human Antithrombin III Sales and Revenue in Global (2017-2022)
  7.8.5 Octapharma Key News

8 GLOBAL HUMAN ANTITHROMBIN III PRODUCTION CAPACITY, ANALYSIS

8.1 Global Human Antithrombin III Production Capacity, 2017-2028
8.2 Human Antithrombin III Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Antithrombin III Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 HUMAN ANTITHROMBIN III SUPPLY CHAIN ANALYSIS

10.1 Human Antithrombin III Industry Value Chain
10.2 Human Antithrombin III Upstream Market
10.3 Human Antithrombin III Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Human Antithrombin III Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Human Antithrombin III in Global Market
Table 2. Top Human Antithrombin III Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Antithrombin III Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Antithrombin III Revenue Share by Companies, 2017-2022
Table 5. Global Human Antithrombin III Sales by Companies, (K Bottles), 2017-2022
Table 6. Global Human Antithrombin III Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Antithrombin III Price (2017-2022) & (US$/Bottle)
Table 8. Global Manufacturers Human Antithrombin III Product Type
Table 9. List of Global Tier 1 Human Antithrombin III Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Antithrombin III Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Form – Global Human Antithrombin III Revenue, (US$, Mn), 2021 & 2028
Table 12. By Form - Global Human Antithrombin III Revenue (US$, Mn), 2017-2022
Table 13. By Form - Global Human Antithrombin III Revenue (US$, Mn), 2023-2028
Table 14. By Form - Global Human Antithrombin III Sales (K Bottles), 2017-2022
Table 15. By Form - Global Human Antithrombin III Sales (K Bottles), 2023-2028
Table 16. By Application – Global Human Antithrombin III Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Antithrombin III Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Antithrombin III Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Antithrombin III Sales (K Bottles), 2017-2022
Table 20. By Application - Global Human Antithrombin III Sales (K Bottles), 2023-2028
Table 21. By Region – Global Human Antithrombin III Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Antithrombin III Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Antithrombin III Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Antithrombin III Sales (K Bottles), 2017-2022
Table 25. By Region - Global Human Antithrombin III Sales (K Bottles), 2023-2028
Table 26. By Country - North America Human Antithrombin III Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Antithrombin III Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Antithrombin III Sales, (K Bottles), 2017-2022
Table 29. By Country - North America Human Antithrombin III Sales, (K Bottles), 2023-2028
Table 30. By Country - Europe Human Antithrombin III Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Antithrombin III Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Antithrombin III Sales, (K Bottles), 2017-2022
Table 33. By Country - Europe Human Antithrombin III Sales, (K Bottles), 2023-2028
Table 34. By Region - Asia Human Antithrombin III Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Antithrombin III Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Antithrombin III Sales, (K Bottles), 2017-2022
Table 37. By Region - Asia Human Antithrombin III Sales, (K Bottles), 2023-2028
Table 38. By Country - South America Human Antithrombin III Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Antithrombin III Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Antithrombin III Sales, (K Bottles), 2017-2022
Table 41. By Country - South America Human Antithrombin III Sales, (K Bottles), 2023-2028
Table 42. By Country - Middle East & Africa Human Antithrombin III Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Antithrombin III Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Antithrombin III Sales, (K Bottles), 2017-2022
Table 45. By Country - Middle East & Africa Human Antithrombin III Sales, (K Bottles), 2023-2028
Table 46. Grifols Corporate Summary
Table 47. Grifols Human Antithrombin III Product Offerings
Table 48. Grifols Human Antithrombin III Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2017-2022)
Table 49. Lee BioSolutions Corporate Summary
Table 50. Lee BioSolutions Human Antithrombin III Product Offerings
Table 51. Lee BioSolutions Human Antithrombin III Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2017-2022)
Table 52. ATryn Corporate Summary
Table 53. ATryn Human Antithrombin III Product Offerings
Table 54. ATryn Human Antithrombin III Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2017-2022)
Table 55. LFB Corporate Summary
Table 56. LFB Human Antithrombin III Product Offerings
Table 57. LFB Human Antithrombin III Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2017-2022)
Table 58. Shire Corporate Summary
Table 59. Shire Human Antithrombin III Product Offerings
Table 60. Shire Human Antithrombin III Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2017-2022)
Table 61. CSL Limited Corporate Summary
Table 62. CSL Limited Human Antithrombin III Product Offerings
Table 63. CSL Limited Human Antithrombin III Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2017-2022)
Table 64. Kedrion Corporate Summary
Table 65. Kedrion Human Antithrombin III Product Offerings
Table 66. Kedrion Human Antithrombin III Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2017-2022)
Table 67. Octapharma Corporate Summary
Table 68. Octapharma Human Antithrombin III Product Offerings
Table 69. Octapharma Human Antithrombin III Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2017-2022)
Table 70. Human Antithrombin III Production Capacity (K Bottles) of Key Manufacturers in Global Market, 2020-2022 (K Bottles)
Table 71. Global Human Antithrombin III Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Human Antithrombin III Production by Region, 2017-2022 (K Bottles)
Table 73. Global Human Antithrombin III Production by Region, 2023-2028 (K Bottles)
Table 74. Human Antithrombin III Market Opportunities & Trends in Global Market
Table 75. Human Antithrombin III Market Drivers in Global Market
Table 76. Human Antithrombin III Market Restraints in Global Market
Table 77. Human Antithrombin III Raw Materials
Table 78. Human Antithrombin III Raw Materials Suppliers in Global Market
Table 79. Typical Human Antithrombin III Downstream
Table 80. Human Antithrombin III Downstream Clients in Global Market
Table 81. Human Antithrombin III Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Human Antithrombin III Segment by Form
Figure 2. Human Antithrombin III Segment by Application
Figure 3. Global Human Antithrombin III Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Antithrombin III Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Antithrombin III Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Antithrombin III Sales in Global Market: 2017-2028 (K Bottles)
Figure 8. The Top 3 and 5 Players Market Share by Human Antithrombin III Revenue in 2021
Figure 9. By Form - Global Human Antithrombin III Sales Market Share, 2017-2028
Figure 10. By Form - Global Human Antithrombin III Revenue Market Share, 2017-2028
Figure 11. By Form - Global Human Antithrombin III Price (US$/Bottle), 2017-2028
Figure 12. By Application - Global Human Antithrombin III Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Antithrombin III Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Antithrombin III Price (US$/Bottle), 2017-2028
Figure 15. By Region - Global Human Antithrombin III Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Antithrombin III Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Antithrombin III Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Antithrombin III Sales Market Share, 2017-2028
Figure 19. US Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Antithrombin III Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Antithrombin III Sales Market Share, 2017-2028
Figure 24. Germany Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Antithrombin III Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Antithrombin III Sales Market Share, 2017-2028
Figure 33. China Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Antithrombin III Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Antithrombin III Sales Market Share, 2017-2028
Figure 40. Brazil Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Antithrombin III Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Antithrombin III Sales Market Share, 2017-2028
Figure 44. Turkey Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Antithrombin III Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Antithrombin III Production Capacity (K Bottles), 2017-2028
Figure 49. The Percentage of Production Human Antithrombin III by Region, 2021 VS 2028
Figure 50. Human Antithrombin III Industry Value Chain
Figure 51. Marketing Channels